Filter
237
Text search:
Polymerase
Chain
Reaction
(PCR)
Featured
Recommendations
40
New Publications
68
Language
Document type
No document type
125
Guidelines
43
Studies & Reports
35
Strategic & Response Plan
13
Manuals
8
Fact sheets
7
Situation Updates
3
Training Material
1
Resource Platforms
1
Online Courses
1
Countries / Regions
India
11
Nigeria
10
Congo, Democratic Republic of
8
Tanzania
8
Liberia
7
Africa
7
Syria
6
Rwanda
6
Global
6
Sierra Leone
5
Ghana
5
Ethiopia
4
Uganda
4
South Africa
4
Zambia
3
Kenya
3
Bangladesh
3
Western and Central Europe
3
Guinea
2
Burkina Faso
2
Cameroon
2
Nepal
2
Malawi
2
Mozambique
2
Namibia
2
Ukraine
2
Myanmar / Burma
2
West and Central Africa
2
Latin America and the Carribbean
2
Venezuela
2
Senegal
1
Côte d’Ivoire / Ivory Coast
1
Saudi Arabia
1
Togo
1
Zimbabwe
1
Philippines
1
Somalia
1
South Sudan
1
Germany
1
Chad
1
Indonesia
1
Central African Republic
1
Argentina
1
Brazil
1
Burundi
1
Colombia
1
Botswana
1
Angola
1
Madagascar
1
Lesotho
1
Yemen
1
Middle East and North Africa
1
South–East Asia Region
1
Georgia
1
Authors & Publishers
Publication Years
Category
Countries
85
Clinical Guidelines
43
Pharmacy & Technologies
14
Public Health
11
Key Resources
6
Women & Child Health
4
Capacity Building
2
Toolboxes
NTDs
29
COVID-19
27
HIV
20
Rapid Response
16
TB
15
Ebola & Marburg
12
Zika
8
AMR
4
2.0 Rapid Response
4
Cholera
3
Conflict
3
Refugee
3
Mental Health
3
Polio
2
Specific Hazards
2
Caregiver
2
Natural Hazards
1
Planetary Health
1
Pharmacy
1
NCDs
1
Malaria
1
Updated 22 august 2016. This document aims to provide interim guidance on the case definition of GBS and strategies to manage the syndrome, in the context of Zika virus and its potential association with GBS. This document is intended to inform the development of local clinical protocols and health
...
As of 12 December 2022, over 645 million people worldwide have been diagnosed with COVID-19, with over 6.6 million deaths (4).
The Omicron variant, which emerged in late November 2021, and its subvariants, are now the dominant circulating viruses, contributing to the ongoing surge in several countr
...
Updated 2022. This guide addresses the care pathway from presentation of the patient to a health facility to patient discharge. It considers different levels of disease severity, from asymptomatic individuals to critically ill patients. Accounting for variations in the benefits and harms of chest im
...
Kassa BMC Infectious Diseases (2018) 18:216 https://doi.org/10.1186/s12879-018-3126-5
The WHO COVID-19 Clinical management: living guidance contains the most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is important.
Interim guidanceAnnex to: Policy considerations for implementing a risk-based approach to international travel in the context of COVID-19, 2 July 2021
At the global, national, and regional levels, there are several guidelines and guides regarding the preparedness, prevention, surveillance, and control of diseases caused by respiratory viruses; most initiatives focus on specific virus events or cases. During the coronavirus disease 2019 (COVID-19)
...
Epidemiologisches Bulletin; 14. März 2016 Nr. 10/11 ;DOI 10.17886/EpiBull-2016-014
Journal of Infection and Public Health 12 (2019) 213–223
Guidelines for Therapy and Management of Urinary Tract Infection
Trypanosoma cruzi is the etiological agent of Chagas disease (CD), considered one of the most important parasitic infections in Latin America. Between 25 and 90 million humans are at infection risk via at least one of multiple infection mechanisms. Under natural conditions, the principal transmissio
...
Abstract: Chagas disease is caused by infection with the protozoan Trypanosoma cruzi, and although over 100 years have passed since the discovery of Chagas disease, it still presents an increasing problem for global public health. A plethora of information concerning the chronic phase of human Chaga
...
